Show simple item record

dc.contributor.authorVeroutis, Den
dc.contributor.authorArgyropoulou, ODen
dc.contributor.authorGoules, AVen
dc.contributor.authorKambas, Ken
dc.contributor.authorPalamidas, DAen
dc.contributor.authorEvangelou, Ken
dc.contributor.authorHavaki, Sen
dc.contributor.authorPolyzou, Aen
dc.contributor.authorValakos, Den
dc.contributor.authorXingi, Een
dc.contributor.authorKaratza, Een
dc.contributor.authorBoki, KAen
dc.contributor.authorCavazza, Aen
dc.contributor.authorKittas, Cen
dc.contributor.authorThanos, Den
dc.contributor.authorRicordi, Cen
dc.contributor.authorMarvisi, Cen
dc.contributor.authorMuratore, Fen
dc.contributor.authorGalli, Een
dc.contributor.authorCroci, Sen
dc.contributor.authorSalvarani, Cen
dc.contributor.authorGorgoulis, Vassillis Gen
dc.contributor.authorTzioufas, AGen
dc.date.accessioned2024-01-29T13:19:50Z
dc.date.available2024-01-29T13:19:50Z
dc.date.issued2023en
dc.identifier.citationVeroutis D, Argyropoulou OD, Goules AV, Kambas K, Palamidas DA, Evangelou K, et al. Senescent cells in giant cell arteritis display an inflammatory phenotype participating in tissue injury via IL-6-dependent pathways. Annals of the rheumatic diseases. 2023 Nov 24. PubMed PMID: 38050005. Epub 2023/12/05. eng.en
dc.identifier.pmid38050005en
dc.identifier.doi10.1136/ard-2023-224467en
dc.identifier.urihttp://hdl.handle.net/10541/626861
dc.description.abstractOBJECTIVES: Age is the strongest risk factor of giant cell arteritis (GCA), implying a possible pathogenetic role of cellular senescence. To address this question, we applied an established senescence specific multimarker algorithm in temporal artery biopsies (TABs) of GCA patients. METHODS: 75(+) TABs from GCA patients, 22(-) TABs from polymyalgia rheumatica (PMR) patients and 10(-) TABs from non-GCA/non-PMR patients were retrospectively retrieved and analysed. Synovial tissue specimens from patients with inflammatory arthritis and aorta tissue were used as disease control samples. Senescent cells and their histological origin were identified with specific cellular markers; IL-6 and MMP-9 were investigated as components of the senescent associated secretory phenotype by triple costaining. GCA or PMR artery culture supernatants were applied to fibroblasts, HUVECs and monocytes with or without IL-6R blocking agent to explore the induction of IL-6-associated cellular senescence. RESULTS: Senescent cells were present in GCA arteries at higher proportion compared with PMR (9.50% vs 2.66%, respectively, p<0.0001) and were mainly originated from fibroblasts, macrophages and endothelial cells. IL-6 was expressed by senescent fibroblasts, and macrophages while MMP-9 by senescent fibroblasts only. IL-6(+) senescent cells were associated with the extension of vascular inflammation (transmural inflammation vs adventitia limited disease: 10.02% vs 4.37%, respectively, p<0.0001). GCA but not PMR artery culture supernatant could induce IL-6-associated senescence that was partially inhibited by IL-6R blockade. CONCLUSIONS: Senescent cells with inflammatory phenotype are present in GCA arteries and are associated with the tissue inflammatory bulk, suggesting a potential implication in disease pathogenesis.en
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1136/ard-2023-224467en
dc.titleSenescent cells in giant cell arteritis display an inflammatory phenotype participating in tissue injury via IL-6-dependent pathwaysen
dc.typeArticleen
dc.contributor.departmentMolecular and Clinical Cancer Sciences, Manchester Cancer Research Centre, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK.en
dc.identifier.journalAnnals of the Rheumatic Diseasesen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record